We have recently shown that insulin signalling at the liver endothelium is disrupted as early as after 3 days of a high fat administration [49], and we confirm here this finding in our CafD model, suggesting that this mechanism could probably be a major contributor to the development of liver endothelial dysfunction in NAFLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.